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Abstract
Approximately 285 million people worldwide suffer from diabetes, with insulin supplementation 
as the most common treatment measure. Regenerative medicine approaches such as a 
bioengineered pancreas has been proposed as potential therapeutic alternatives. A bioengineered 
pancreas will benefit from the development of a bioscaffold that supports and enhances cellular 
function and tissue development. Perfusion-decellularized organs are a likely candidate for use in 
such scaffolds since they mimic compositional, architectural and biomechanical nature of a native 
organ. In this study, we investigate perfusion-decellularization of whole pancreas and the 
feasibility to recellularize the whole pancreas scaffold with pancreatic cell types. Our result 
demonstrates that perfusion-decellularization of whole pancreas effectively removes cellular and 
nuclear material while retaining intricate three-dimensional microarchitecture with perfusable 
vasculature and ductal network and crucial extracellular matrix (ECM) components. To mimic 
pancreatic cell composition, we recellularized the whole pancreas scaffold with acinar and beta 
cell lines and cultured up to 5 days. Our result shows successful cellular engraftment within the 
decellularized pancreas, and the resulting graft gave rise to strong up-regulation of insulin gene 
expression. These findings support biological utility of whole pancreas ECM as a biomaterials 
scaffold for supporting and enhancing pancreatic cell functionality and represent a step toward 
bioengineered pancreas using regenerative medicine approaches.
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1. INTRODUCTION
Diabetes mellitus is a global disease with immense economic and social burden. According 
to the World Health Organization, at least 285 million people worldwide suffer from 
diabetes [1]. While pharmaceutical interventions and insulin supplementation are the most 
commonplace treatment of diabetes, these do not represent a cure and can potentially lead to 
long term complications [2]. Advances in tissue engineering have facilitated the 
development of replacement tissues or organs for the treatment of injured or degenerative 
soft tissue [3–5]. The development of a bioengineered pancreas by appropriate combination 
of cells, biomaterial scaffolds and biologically active molecules could provide an alternative 
avenue for diabetes therapy.
Three-dimensional (3D) scaffold plays a critical role in regenerative medicine and tissue 
engineering. For example, cell-scaffold interactions are important for the regulation of 
cellular behavior, including pancreatic islet-cell survival and insulin production through 
integrin-mediated activation and downstream signaling events [6, 7]. Native tissues and 
organs are comprised of unique extracellular matrix (ECM) compositions, microstructures 
and biomechanical properties, which maintain distinct signals for resident cells [8, 9]. 
Ideally, a tissue engineered scaffold would provide the same or similar microenvironmental 
niche to the seeded cells as that of a native ECM. Therefore, at present, the development of 
pancreatic tissue engineering scaffolds have focused on recreating milieu similar to the 
native islet and surrounding ECM (summarized in review by Cheng et al. [10] and Candiello 
et al. [11]). Various synthetic and natural biomaterials have been exploited in this field with 
the objective to restore the critical signal loss between native islet cells and their ECM 
environment following islet isolation. Most of these tissue engineering scaffolds, however, 
use a purified single ECM protein and do not mimic the intricacy of the pancreatic ECM 
composition and ultrastructure. Recently there has been a shift towards multiple-matrix 
systems of purified proteins, which have been shown to improve stem cell proliferation and 
differentiation [12, 13] and promote isolated islet and β-cell survival and function [14, 15]. 
Natural ECM derived from native tissues and organs can meet this requirement by providing 
a more physiologically relevant scaffold that recapitulates the complex in vivo 
microenvironment.
The novel concept of whole organ perfusion decellularization has been described recently to 
generate native ECM scaffolds from complex organs such as heart [16–19], liver [20–23], 
lung [24–29], kidney [30–32] and more recently pancreas [33–36]. Whole organ acellular 
matrices provide an attractive scaffold for the repopulation with cells for an engineered 
tissue/organ because of the physiological resemblance of the original tissue, including intact 
3D anatomical architecture, preserved spatial array of ECM components, vascular network, 
and biomechanical properties. Prior studies have shown the positive effect of endothelial cell 
derived ECM for the enhancement of islet and β-cell attachment and proliferation [37, 38]. 
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Other works have also shown improved islet functionality when cultured on decellularized 
matrices derived from small intestinal submucosa (SIS) [39, 40] and pancreatic slices [36, 
41]. Decellularized pancreas work described by De Carlo et al. [41] and Mirmalek-Sani et 
al. [36] revealed the benefits of 2D decellularized pancreas slices to support and maintain 
islet functions. These initial studies clearly motivate the need and indicate the potential 
benefits that can be attained by a whole organ 3D reconstruction of pancreas. The 
importance of 3D scaffold is well recognized for a better representation of the complex in 
vivo microenvironment and is important for proper regulation of cell behavior [42], yet 
recellularization of whole pancreas 3D scaffold remains to be demonstrated. We hypothesize 
that the optimal scaffold to support pancreatic tissue engineering may be the natural 3D 
ECM scaffold of the whole pancreas. To this effect, we propose that perfusion-
decellularization of whole pancreas yields an acellular scaffold suitable for pancreatic tissue 
and organ engineering.
The present study investigated the possibility of generating an acellular whole pancreas 
scaffold by a perfusion decellularization technique and utilizing this biomaterial as a 
scaffold to support pancreatic tissue engineering and whole organ regeneration. Toward this 
end, we characterized the resultant native pancreatic ECM-scaffold for preservation of ECM 
composition, 3D structural integrity, and biomechanical properties. We then repopulated the 
decellularized pancreas with endocrine and exocrine cell types to demonstrate the feasibility 
of recellularization. Furthermore, the effects of pancreas derived ECM scaffold on 
modulating cellular functionality such as insulin gene expression was determined.
2. METHODS
2.1 Mouse pancreas harvest and cannulation
All animal work performed was in accordance with animal welfare act, institutional 
guidelines and approved by Institutional Animal Care and Use Committee of the University 
of Pittsburgh). Female ICR mice (Taconic), between the ages of 6–12 weeks were 
euthanized by CO2 inhalation followed by cervical dislocation. Sterile conditions were 
observed when removing the pancreas. A laparotomy was performed and a 24 G catheter 
was inserted approximately 1 cm into the anterior hepatic portal vein and sutured in place. 
The distal end of the superior mesenteric vein and large branches of splenic arteries and 
veins were carefully ligated to prevent leakage. The pancreas was then carefully dissected 
free from all adjacent structures including the stomach, intestine, spleen and mesenteric 
tissue.
2.2 Perfusion decellularization of mouse pancreas
The isolated pancreas was connected to a perfusion system to allow retrograde perfusion at 
8ml/min, in which solutions flowed through the hepatic portal vein, into the splenic vein, 
and throughout the vasculature of the pancreas. Next, ionic detergent, 0.5% SDS 
(Invitrogen) in deionized water was used as perfusate to rinse cells and cell debris out of the 
pancreas. After the tissues became translucent (about 325 min), subsequent steps of 
perfusion were 15 min of deionized water perfusion and 15 min of 1% Triton X-100 (Sigma 
Aldrich) in deionized water. A solution of benzonase (90U/ml, Sigma) was perfused for 15 
Goh et al. Page 3













min and a final washing step of 10% fetal bovine serum (FBS, Life Technologies) in PBS 
with Pen/Strep (100U/ml) perfused the pancreas for additional 48 hours to clear remaining 
cellular debris.
2.3 Cell culture
The AR42J acinar cell line (CRL-1492, ATCC, VA, USA) was used at passage 18–25. 
AR42J was cultured inF-12K medium (ATCC, VA, USA) supplemented with 20% FBS 
(Life Technologies) and 100 U/ml penicillin/streptomycin (Life Technologies) on T75 tissue 
culture flasks. The MIN-6 β-cell was used at passage 19–26. MIN-6 was cultured in 
Dulbecco’s modified Eagle’s medium (Life Technologies) supplemented with 15% FBS 
(Life Technologies) and 100 U/ml penicillin/streptomycin (Life Technologies) on T75 tissue 
culture flasks. Both cell types were cultured at 37°C and in a 95% air/5% CO2 atmosphere.
2.4 In vivo implantation of decellularized pancreas
All animal work was approved by the Institutional Animal Care and Use Committee of the 
University of Pittsburgh. For preliminary biocompatibility studies, a 1 cm2 perfusion-
decellularized pancreas construct was surgically placed within a dorsal subcutaneous pocket 
of an adult mouse. Female C57BL/6 mice, age 6–8 weeks, were purchased from Jackson 
Laboratories (Bar Harbor, ME). The mouse was anesthetized and maintained at a surgical 
plane of anesthesia with 1.5–2.5% isoflurane in oxygen and positioned in dorsal 
recumbency. The surgical site was prepared in sterile fashion using 70% isopropyl alcohol 
followed by the placement of sterile drapes. For the subcutaneous surgical implantation: A 
central longitudinal incision measuring approximately 1.5 cm in length was made in the 
epidermis, dermis, and fascia to expose the underlying muscle tissue on the dorsal side. 
Dermal layers and underlying connective tissue was undermined to create a pocket with 
similar size to the implant construct. The decellularized pancreas construct was sutured to 
the underlying muscle with four non-absorbable marking sutures (3-0 prolene) and the skin 
was closed over the implant site in uninterrupted fashion. A minimal amount of suture 
material was placed only at the construct corners to avoid eliciting a host response to the 
suture that would obscure the host response to the implanted material. The incision was 
covered in betadine ointment after closure and assessed for signs of infection for2 days 
postsurgery. The mouse received Buprenex (buprenorphine hydrochloride, 0.25 mg/kg) for 
analgesia, and Baytril (enro oxacin, 20 mg) an antibiotic, for 3 days postoperatively. The 
animal survived the surgical procedure and its predetermined study period without 
complications. After 14 days the mouse was euthanized with 5% iso urane in oxygen 
followed by an intracardiac injection of potassium chloride to induce cardiac arrest. 
Following euthanasia the implant along with the surrounding skin and muscle were 
harvested and fixed in 10% NBF for histologic evaluation.
2.5 Recellularization and culture of seeded-pancreatic construct
MIN-6 cells (30×106) were trypsinized and diluted in 3mL of medium. The cell suspension 
was introduced into the decellularized pancreas by means of retrograde gravity perfusion via 
the hepatic portal vein in 3 steps, 1mL each, with 20 min interval between each step. MIN-6 
seeded pancreas was immersed and cultured in the same MIN-6 cell culture medium 
described above for 5 days. For co-recellularization strategy, AR42J was used as the second 
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cell type for the recellularization. Similarly, AR42J (30×106 cells) were trypsinized and 
diluted in 3mL of medium. The AR42J cell suspension was inoculated into the pancreas by 
retrograde perfusion through the pancreatic duct but the MIN-6 cells were introduced 
through the vasculature. The two cell types were seeded in sequence, with the same multi-
step repopulation mentioned for single-cell type seeding. Cells were allowed to attach for 2 
hours before introducing a gentle rinse through both the hepatic portal vein and pancreatic 
duct in order to wash out any unattached cells. The cell-seeded pancreatic construct was left 
undisturbed and submerged in co-recell culture medium (DMEM/F12 supplemented with 
15% FBS and 100 U/ml Pen/Strep). Both cannulation to the portal vein and pancreatic duct 
were kept intact to allow perfusion feeding of media every day. The seeded pancreas was 
cultured under static conditions at 37°C with a 95% air/5% CO2 atmosphere for 5 days.
2.6 MIN-6 seeded on different ECM substrates and 2D thin slices of decellularized 
pancreas
Growth factor-reduced Matrigel (BD) was used as a thin coating according to 
manufacturer’s instruction. Collagen IV (BD) and fibronectin (Milipore) were used at a 
concentration of 5 mg/ml. These ECM substrates were used for coating non-tissue culture-
treated 12-well plates (BD). Collagen type I (BD) was used as 5 mm thick gels. Coated and 
untreated (UT) plates were blocked with 1% BSA (Sigma). Control culture was conducted 
on UT plates blocked with 1% BSA (Sigma). To prepare thin decellularized pancreata slices, 
decellularized pancreata were filled with 1.1% alginate solution, and submerged in 100mM 
Calcium Chloride solution to crosslink the alginate. The solidified pancreas was sliced with 
a tissue slicer (Thomas Scientific) to yield thin, uniform, transverse sections. The alginate 
within the thin slices of pancreas were dissolved in a sterile dissolution buffer consisting of 
50 mM tri-sodium citrate dihydrate (Sigma), 77 mM sodium chloride (VWR International, 
Leicestershire, UK), and 10 mM HEPES (Sigma) in PBS for 15–20 min while stirring gently 
at room temperature. Finally, the thin slices of pancreas were rinsed and covered with sterile 
PBS with Pen/Strep (100U/ml), and placed at 4°C until use. Cloning cylinder (Fisher) was 
applied and sealed with sterile silicone grease (Dow Corning) to the pancreatic slice to 
consolidate the seeded cells only to the pancreatic slice. MIN-6 cells (25,000 cells/cm2) 
were cultured on these various different ECM substrates for 5 days before harvest for qPCR 
analysis.
2.7 Two-photon microscopy
Two-photon microscopy was performed with an upright Olympus FV1000 MPE multi-
photon microscope (Olympus, Central Valley, PA, USA) and a Mai Tai DeepSee 
femtosecond-pulsed laser (Spectra-Physics, Santa Clara, CA, USA) tuned at 800 nm. The 
pancreatic slice was line-scanned and fluorescence emission was captured by three non-
descanned external photomultiplier tube (PMT) detectors coupled to the following long-pass 
dichroic mirrors and band pass emission filters: 505 nm mirror and 460–500 nm filter (blue 
channel), 570 nm mirror and 520–560 nm filter (green channel) and 575–630 nm filter (red 
channel). The pancreatic slice was placed on an imaging dish having a #1.5 coverslip and 
immersed in PBS. Fixed xy planes spanning 505 × 375 μm at a resolution of 0.994 μm/pixel 
and depth of 1–50 μm from the surface of scaffold were imaged using a high numerical 
aperture (NA = 1.05), water-immersion 25X objective.
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Native, decellularized and recellularized pancreas were fixed, sectioned and stained 
following protocol previously described [43]. Briefly, tissue samples were fixed with 4% 
formaldehyde (ThermoFisher), cryoprotected with 30% sucrose and cut into 7 μm thick 
sections. For immunostaining, the following primary antibodies were used: rabbit anti-
laminin, rabbit anti-collagen I, rabbit anti-collagen IV, rabbit anti-fibronectin (Abcam, 
1:200), rabbit anti-Cpeptide (Cell signaling, 1:100) and rabbit anti-α-Amylase (Sigma 
Aldrich, 1:200). Secondary antibodies used were: donkey anti-rabbit Alexafluor 488 (1:500, 
Invitrogen) and donkey anti-rabbit Alexafluor 555 (1:500, Invitrogen). For co-labeling using 
antibodies from the same host species, sequential staining was conducted. After the first 
primary antibody staining, an additional blocking step was included prior to the addition of a 
second primary antibody. For actin staining, phalloidin rhodamine (Cytoskeleton, 1:200) 
was implemented and stained for 30 min in the dark. The slides were washed again three 
times with 1× PBS (5–10 min) each before being mounted with ProLong® Gold Anti-fade 
Reagent with DAPI (Invitrogen). Images were recorded with Metamorph 7.5.6.0 (Molecular 
Device) on an Olympus IX81 inverted microscope (Olympus, Central Valley, PA, USA).
2.9 ECM digestion and proteomics analysis
The ECM pellet was digested for 2h with each of the following enzymes: 0.15 mU/μl 
heparan sulfate lyase and chondroitin ABC lyase from Flavobacterium heparinum and 
Proteus vulgaris, respectively (Seikagaku Corporation, Japan) and washed in PBS. The 
ECM proteins were dissolved in 8M urea and 1x reducing SDS sample buffer. The proteins 
from the ECM preparation were separated on 3.5–15% gradient SDS PAGE under reducing 
conditions [44]. The gel lane was divided into 11 slices and taken through a typical in-gel 
digestion procedure. Briefly, gel bands were destained, reduced with 2.5mM tris (2-
carboxyethyl) phosphine and alkylated with 3.75mM iodoacetamide, followed by in-gel 
digestion with 13ng/μl of trypsin (Promega) overnight at 37°C. Peptide digests were 
analyzed by nano Liquid Chromatography-tandem mass spectrometry (LC-MS/MS), on a 
Thermo Fisher LTQ OrbitrapVelos connected to a Waters Acquity UPLC system (Waters 
Corp., Milford, MA), using a 90 minute gradient. Protein identification was performed with 
Proteome Discoverer 1.3 using the Sequest search engine. Database searches used the 
Uniprot complete mouse database (downloaded in December 2012 merged with a 
contaminant database from ABSciex, 50838 sequences, 24435643 residues). Settings were 
for a full trypsin digest, with two missed cleavages, one static modification (cysteine 
carbamidomethylation), two dynamic modifications (oxidized methionines and 
hydroxyproline), mass tolerance of 10 ppm for precursor mass and 0.5 Da for fragment 
masses. Percolator, a post-processing software using a target/decoy database approach, was 
used to evaluate the accuracy of peptide identifications. Peptide identifications were filtered 
with a q-value cutoff of 0.01 (1% global False Discovery Rate, FDR). Proteins were grouped 
using the maximum parsimony principle and this list was imported to ProteinCenter 
(Thermo) and compared with the IPI mouse database for statistical analysis to identify over-
represented Gene Ontology terms and functional classification.
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The decellularized pancreata (n=3) were digested with papain solution at 60°C for 6 h. The 
native pancreata (n=3) were digested in papain solution as controls. Papain (Sigma Aldrich) 
was dissolved at 400 mg/ml in 0.1 M phosphate buffer (pH 6.0), with 5 mM cysteine 
hydrochloride (Sigma Aldrich), and 5 mM EDTA (Sigma Aldrich). The lysates were used 
for detection of the DNA and sulfated glycosaminoglycan (sGAG) content. A DNA 
quantification kit - Quant-iT™ PicoGreen® dsDNA Assay kit (Invitrogen) was used to 
measure DNA content according to manufacturer’s instruction. The fluorescence reading 
(excitation: 485 nm and emission: 528 nm) was taken on a plate reader (Synergy 2, Biotek), 
and the absolute amount of DNA (ng/mL) was quantified against a lambda DNA standard 
curve (0 ng/mL– 1000 ng/mL).
2.11 sGAG content characterization
For qualitative determination of presence of GAG, Alcian Blue staining was done according 
to manufacturer’s instruction (Newcomer Supply). Briefly, slides were deparaffinized and 
hydrated through graded ethyl alcohols to distilled water. Next, slides were placed in 3% 
acetic acid for 3 min and then directly into 1% Alcian Blue solution pH 2.5 and stained for 
30 min in room temperature. The slides were washed in running tap water for 10 min 
followed by a distilled water rinse. The counterstaining was done in Nuclear Fast Red stain 
for 5 min before rinsing, dehydrated through graded ethyl alcohol and cleared in xylene. The 
slides were mounted with xylene mounting medium. For qualitative measure of sGAG, the 
method to produce lysate for DNA quantification was used here as well. A sGAG 
quantification kit–Blyscan Sulfated Glycoaminoglycan Assay kit (Biocolor) was used to 
measure sGAG according to manufacturer’s instruction. Briefly, the specimen lysate was 
mixed with Blyscan dye to bind the GAG. The GAG-dye complex was then collected by 
centrifugation. After the supernatant was removed and the tube drained, the dissociation 
reagent was added. 100 μl solutions were transferred into a 96-well plate. Absorbance 
against the background control was obtained at a wavelength of 656 nm on a microplate 
spectrophotometer and the GAG amount was calculated based on a standard curve obtained 
with the standard GAG supplied with the kit.
2.12 Scanning electron microscopy (SEM) and transmission electron microscopy (TEM)
Native and decellularized pancreata were fixed in 2.5% glutaraldehyde in 0.1 M PBS (pH 
7.4) for 60 minutes. The samples were washed thoroughly in 3 changes 0.1 M PBS for 15 
minutes each. Next, the samples were fixed in 1% OsO4 in 0.1 M PBS for 60 minutes. This 
was followed by another 3 changes of PBS washing steps for 15 minutes each. The samples 
were then dehydrated in gradient series of alcohol for 15 min each. Additionally, samples 
were critical point dried and coated with Au/Pd using a Cressington Coater 108A sputter 
coater. Electron microscope images were taken using a Jeol JSM-6335F field emission 
SEM. For TEM, the tissue sample was fixed in 2.5% glutaraldehyde in PBS. The tissue 
sample were post-fixed in 1% osmium tetroxide in PBS, dehydrated through a graded series 
of alcohols and embedded in Epon (Energy Beam Sciences, Agawam, MA). Thin (60-nm) 
sections were cut using a Reichert Ultracut S (Leica, Deerborn, MI), mounted on 200 mesh 
copper grids and counterstained with 2% aqueous uranyl acetate for 7 min and 1% aqueous 
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lead citrate for 2 min. Observation was with a JEOL 1011 transmission electron microscope 
(Peabody, MA)
2.13 Preparation of pancreatic tissue for atomic force microscopy (AFM) measurement
Both native and decellularized unfixed samples from murine pancreas were cryoprotected by 
soaking in 30% sucrose solution in PBS for 24 hours. The entire murine pancreas was then 
set in a mold and covered in OCT cold embedding media and frozen by exposure to dry ice 
overnight. The OCT block containing the pancreas was cryosectioned to a thickness of 20 
microns and mounted on SuperFrostPlus glass slides. All samples were thawed in PBS for 
30 minutes prior to testing.
2.14 AFM measurement of pancreatic tissue stiffness
AFM force indentation measurements were performed using the MFP-3D Atomic Force 
Microscope (Asylum Research, CA, USA), mounted on top of an Olympus IX-71 
fluorescence microscope (Olympus, Tokyo, Japan). All force measurements and analysis 
was done using the MFP3D software (Asylum Research) built on IgorPro 6 (Wavemetrics) 
as previously described [45]. For all measurements a glass silica sphere (radius 3.5 micron) 
was attached to the tip of a 100 micron silicon nitride cantilever (Veeco Systems) with a 
spring constant of ~0.6 N/m. The stiffness of each alginate gel was measured at n= 16 
random locations on each sample. The Sneddon model was used to determine the gel 
stiffness from the force indentation plots.
2.15 Quantitative RT-PCR
RNA was extracted using NucleoSpin kit according to the manufacturer’s protocol. The 
sample absorbance at 280 nm and 260 nm was measured using a BioRad Smart Spec 
spectrophotometer to obtain RNA concentration and quality. Reverse transcription was 
performed using ImProm II Promega reverse transcription kit following the manufacturer’s 
recommendation. qRT-PCR analysis was performed for insulin markers, ins1 and ins2.
The cycle number at the threshold level of log-based fluorescence is defined as Ct number, 
which is the observed value in most real-time PCR experiments, and therefore the primary 
statistical metric of interest. ΔCt is equal to the difference in threshold cycle for target and 
reference or control (ΔCt = Cttarget−Ctreference). ΔΔCt is equal to the difference between 
ΔCtsample and ΔCtcontrol (ΔΔCt = ΔCtsample−ΔCtcontrol). The fold change of a target gene is 
defined by, fold change = 2−ΔΔCt. qRT-PCR analysis was repeated in triplicate.
2.16 Statistical analysis
Quantification data were expressed as mean ± SD. Significant differences among groups 
were determined by Wilcoxon rank-sum test for two-group comparisons or ANOVA 
followed by post-hoc analysis for multiple group comparisons. Probability values at P < 
0.05 (*) indicated statistical significance.
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3.1 Perfusion-decellularization of whole organ pancreas
Isolated mouse pancreata were cannulated and retrograde perfused via hepatic portal vein 
with anionic based detergent, 0.5% SDS to remove cellular content. Alternately, retrograde 
perfusion via pancreatic duct was also attempted for pancreas decellularization, however the 
process took longer and was also less effective in cell removal (data not shown). 
Macroscopically, a gradual change of color was observed during the perfusion 
decellularization process (Fig. 1A–D). Perfusion was continued until whole pancreas turned 
completely translucent (about 325 min) as depicted in Fig. 1D. This generated an acellular 
pancreas scaffold while retaining the gross anatomical structure of the pancreas. Histological 
examination by H&E staining showed no remnant cells after the completion of 
decellularization (Fig. 1E). Immunostaining of two major constituents in native pancreas–
acinar cells (Amylase) and β-islet cells (C-peptide) confirmed no residual presence of major 
pancreatic markers in the decellularized pancreas (Fig. 1F). To further assess the efficacy of 
decellularization, DNA quantification was performed using Picogreen assay. Picogreen 
analysis showed that DNA content decreased from 7442.3 ± 2450.2 ng/mg dry weight in 
normal pancreas to 41.3 ± 11.9 ng/mg dry weight in decellularized pancreas (P < 0.01) (Fig. 
1G). These results suggest that perfusion mediated decellularization of pancreas efficiently 
removes pancreatic cellular components. Feasibility of this perfusion decellularization 
technique in human-sized organ was also demonstrated by decellularization of bovine 
pancreas (supplemental 1).
3.2 ECM characterization: immunohistochemistry and mass spectrometry-based 
proteomics analysis
To first characterize the decellularized pancreas, immunohistochemical (IHC) staining was 
performed for the evaluation of major ECM components’ spatial presence relative to that of 
native pancreas. In native pancreas, the ECM is composed primarily of networks of 
collagens and other structural proteins filled with a hydrogel of proteoglycans [46, 47]. IHC 
staining showed that collagen I, IV, fibronectin and laminin were detected in the native 
pancreas (Fig. 2A). After decellularization, all four major ECM components were preserved, 
without any detectable DAPI or actin staining (Fig. 2B). This finding suggests complete 
removal of cellular and cytoskeletal elements while maintaining the ECM composition. In 
addition, the resulting ECM structure and fibril orientation looked identical to that of the 
native organ (Fig. 2B). The preservation of sulfated glycosaminoglycan (sGAG) proteins 
was evaluated qualitatively by alcian blue staining (Fig. 2C), which demonstrated that 
sGAG proteins were retained after decellularization process. In addition, sGAG content was 
also assessed quantitatively using a blyscan assay which demonstrated considerable 
retention of sGAG content in the decellularized pancreas, amounting to 52% of that in native 
pancreas (P<0.01) (Fig. 2D).
Insolubility of the ECM is a challenge to characterizing the pancreatic ECM proteome by 
mass spectrometry-based proteomics. In order to improve solubility, pancreatic ECM was 
deglycosylated to remove GAG side chains of proteoglycans followed by solubilization in 
high molar urea. A GeLC-MS/MS proteomics approach was used whereby the high 
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molecular weight ECM proteins were separated by low percentage 1D gels, in-gel trypsin 
digested followed by LC-MS/MS analysis. Database searching used stringent 1% false 
discovery rate to report protein identifications. After protein grouping, a total of 114 unique 
proteins were identified in the pancreatic ECM (Supplemental table 1), the majority of 
which belonged to the ECM family based on Gene Ontology (GO) Cellular localization. The 
entire list of identified proteins was compared with the reference IPI mouse database to 
identify overrepresented GO cellular localization terms. The topmost GO terms included 
ECM and basement membrane (data not shown); suggesting that the decellularization 
process successfully removes cellular proteins yet preserves the ECM components. Table 1 
is a categorized list of collagens, laminins, proteoglycans and ECM associated proteins.
3.3 Biophysical characterization: structural and mechanical properties of decellularized 
pancreas
Integrity of the vasculature within the decellularized pancreas was analyzed by trypan blue 
dye retrograde injection through hepatic portal vein to visualize the continuity of the 
circulatory branching (Fig. 3A). Rapid diffusion through the vascular tree was also observed 
(Fig. 3A). Transmission electron microscopy (TEM) and scanning electron microscopy 
(SEM) were performed to evaluate the effect of the decellularization procedure on the 3D 
architecture and ECM micro-structures of the decellularized pancreas. TEM analysis 
revealed intact basement membrane and organized fibers of collagen preserved upon 
decellularization (Fig. 3B–C). SEM analysis of the cross-sectional images of the 
decellularized pancreatic constructs revealed that large ductal structures were retained 
whereas the microvilli cells lining the ducts were removed (Fig. 3D–E). Nanofibrous 
structures of the ECM were well retained within the parenchyma (Fig. 3F–G). Hollow and 
void spaces observed within the decellularized pancreas are likely attributes of the 
“footprints” left from pancreatic cells removed during the decellularization process (Fig. 
3H). The recognizable scalloping pattern of arteries also indicates the preservation of 
vascular structure likely branched from the greater pancreatic artery (Fig. 3I). These results 
suggest that perfusion decellularization of the pancreas adequately retained the ultrastructure 
and architecture of the native pancreas. Biomechanical characteristics of the decellularized 
pancreas were analyzed using AFM. Representative cantilever displacement/sample 
deflection curves (Fig. 4A) shows that there was a discernible difference between the native 
and decellularized pancreas, with the stiffer decellularized sample having a much steeper 
slope. Young’s modulus as determined from the AFM curves was found to be 1210±77 Pa 
for native mouse pancreas, while the Young’s modulus of decellularized pancreas is on 
average 3 times greater (3736±1893 Pa) (Fig. 4B).
3.4 In vivo response to decellularized pancreas
Pancreas ECM was implanted subcutaneously in order to preliminarily evaluate in vivo 
biocompatibility in a mouse model. At 14 days post-surgery, histological analysis of the 
subcutaneous implantation site showed the presence of mononuclear cells surrounding the 
partially degraded ECM (Fig. 5A) The pancreas ECM was non-cytotoxic after 14 days and 
like other efficiently decellularized ECM scaffolds [48, 49], was not associated with 
presence of multinucleate foreign body giant cells or other pathological signs of the foreign 
body response (Fig. 5B). Furthermore, active angiogenesis was a feature of the 
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decellularized pancreas implantation site (Fig. 5B, arrows). These preliminary results 
suggest that the perfusion-decellularized pancreas ECM described herein represents a 
cytocompatible scaffold capable of integrating within host tissue.
3.5 Recellularization of decellularized pancreatic scaffold
To evaluate the potential of decellularized pancreas as a scaffold for pancreatic tissue 
engineering, it was recellularized using relevant pancreatic cell lines. We first explored the 
effect of two dimensional (2D) slices of decellularized pancreatic matrix as a substrate for 
cell culture (Fig. 6A). Decellularized pancreatic matrix was cut into slices of about 10–20 
μm thickness, as evaluated by multi-photon microscopy (Fig. 6B). MIN-6 cells (25,000 
cells/cm2) were seeded on the 2D slice and cultured for 5 days. After 5 days, MIN-6 cells 
were found attached and spread on the surface of 2D slice (Fig. 6C).
To evaluate whole organ recellularization potential, endocrine β cell line, MIN-6 cells 
(30×106) were first seeded into the decellularized pancreas via hepatic portal vein by 
multistep infusion technique following the seeding strategy described for liver 
recellularization [20, 21]. Approximately 10×106 cells were introduced at each step, for a 
total of 3 steps, with 20-min intervals between each step. Upon cell seeding, a uniform color 
change was observed throughout the whole decellularized pancreas, indicating a 
homogenous cell delivery (Fig. 7A–B). The repopulated pancreas was then maintained in 
static culture for 5 days with culture media changed by perfusion through the pancreas every 
day. After 5 days, the reconstructed pancreas was analyzed for engraftment, survival and 
functionality by IHC. From the histology, MIN-6 cells appeared to be engrafted both 
surrounding the parenchymal region and around the larger vessels (Fig. 7C). TUNEL 
staining detected only minimal apoptosis (<18%), suggesting that the 3D decellularized 
pancreas scaffold is cytocompatible and supportive of cell growth (Fig. 7D). Furthermore, 
these engrafted cells maintained their insulin expression over 5 days as evidenced by 
positive C-peptide staining (Fig. 7F).
The native pancreas is a dual-functioning glandular organ comprised and capable of both 
endocrine and exocrine tissue and function, to this end, next the decellularized pancreas was 
reconstructed with both the endocrine β cell line (MIN-6) and exocrine acinar cell line 
(AR42J) by simultaneous seeding. The β cells were perfused through the hepatic portal vein 
as before, while the acinar cells were perfused through the pancreatic duct (Fig 8A). The two 
cell types were seeded in sequence, with the hepatic duct perfusion of the MIN6 cells 
preceding the pancreatic duct perfusion of acinar AR42J cells. This seeding strategy 
attempts to retain the cellular composition of native pancreas and the anatomical proximity 
of the cells to different secretory locations: (i.e.; endocrine β cells–vasculature; exocrine 
acinar cells–ductal system). As before, the dual cell-seeded pancreas constructs was 
maintained for up to 5 days in static culture. At day 5, IHC analysis showed that both cell 
types attached and localized to their specific topographical locations as a result of their 
different cell seeding route (Fig. 8B). Immunofluorescence staining confirmed the 
expression of C-peptide, as an analogue of insulin marker identifying endocrine β-cells and 
amylase as a digestive enzyme identifying exocrine acinar-cells (Fig. 8B, C). Most C-
peptide+ cells were localized to the luminal spaces of large vessels and parenchymal regions 
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similar to that observed in single cell reconstructed pancreas. Distinct from the localization 
of C-peptide+ cells, tubular ductal spaces lined with acinar cells expressing amylase were 
observed (Fig. 8C). No inter-dispersed population of the two cell types were observed within 
the engraftment region, suggesting the preservation of the distinct architecture of vasculature 
and ductal structure (Fig. 8C). These results indicate that the decellularized pancreas is 
capable of supporting multiple pancreatic cell types and this co-seeding strategy allows the 
reconstitution of major cellular constituents as in the native pancreas.
3.6 Modulation of β-cell insulin gene expression by native pancreatic ECM
Both primary pancreatic islets and individual isolated pancreatic β-cells have been 
demonstrated to have better in vitro function when cultured on ECM-derived substrates [37, 
39–41, 50] and purified ECM proteins [15, 38, 51, 52]. Having confirmed engraftment and 
survival of the relevant pancreatic cell types in the native pancreatic scaffold, the 
contribution of this pancreas-derived ECM scaffold on cell function was next evaluated by 
the insulin gene expression level. For comparative evaluation, control cultures of MIN-6 
cells (25,000 cells/cm2) were plated on surfaces with the following ECM proteins: collagen 
I, collagen type IV, fibronectin, and growth factor-reduced (GFR) Matrigel. In addition, the 
MIN-6 cells were also cultured on 2D slice configurations of pancreatic ECM for 
comparison between the effects of 2D versus 3D culture configurations. Upon plating, the 
MIN-6 cells readily attached to all tested substrates and remained viable over the culture 
period (data not shown). The cells were cultured for 5 days, after which the cell lysate was 
analyzed for insulin gene expression (ins1 and ins2 expression) by qRT-PCR (Fig. 9). 
Quantitative RT-PCR of MIN-6 demonstrated significantly higher ins1 and ins2 gene 
expression when cultured on these ECM proteins and pancreatic ECM scaffold (P<0.05) 
compared to control (untreated plate) with the exception of collagen I gel. Among the ECM 
proteins tested, collagen IV and fibronectin substrates induced similar insulin gene 
expression levels. Matrigel promoted the highest insulin gene expression (6.9-fold ins1 and 
4.1-fold ins2). MIN-6 seeded on 3D pancreatic ECM exhibited higher insulin gene 
expression than 2D pancreatic ECM. Furthermore, 3D pancreatic ECM also demonstrated 
higher insulin gene expression when compared to single ECM proteins such as collagen IV 
and fibronectin but displayed similar level of insulin gene expression with the Matrigel 
coated surface (no significant difference). These results clearly demonstrate that β-cells 
interact closely with the ECM substrates, and that interaction with specific substrates can 
significantly affect insulin gene expression. The native organ derived of decellularized 
pancreas was found to have a strong positive attribute to ins1 and ins2 gene expression, 
comparable to Matrigel coating and significantly higher than other tested single purified 
molecules.
4. DISCUSSION
The production of an intact acellular organ such as the pancreas by perfusion-
decellularization offers a promising alternate approach for pancreatic tissue engineering and 
functional organ replacement. Herein, we demonstrate that perfusion-decellularization of 
whole pancreas results in the generation of a natural pancreas ECM scaffold with a 
perfusable vascular tree, ductal network and intact 3D architecture, which acts as a suitable 
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template for pancreatic tissue engineering and whole organ regeneration. Comprehensive 
characterization of the decellularized pancreatic matrix showed the preservation of complex 
multi-faceted ECM proteins, 3D spatial orientation and microstructure, and relative stiffness 
of native pancreas. Decellularized pancreatic matrix was non-cytotoxic, and promoted 
angiogenesis when subcutaneously implanted in a mouse model. Repopulation of 
decellularized pancreas with pancreatic cells showed the cytocompatibility of the scaffold. 
The recellularized constructs maintained their respective phenotypic expression (β-cells: C-
peptide; acinar cells: Amylase) after 5 days of culture. Finally, we demonstrated that the 
decellularized pancreas matrix is supportive of β-cell function, as evidenced by the strong 
up-regulation of insulin gene expression.
The objectives for successful decellularization are 1) complete or near complete removal of 
cellular material, and 2) preservation of ECM composition [53]. Commonly reported 
decellularization protocols require mechanical agitation or freezing and thawing which may 
take up to days or weeks to remove all cellular materials [54–56]. Such protocols do not 
guarantee preservation of the ECM microstructure, which has been shown to be instrumental 
for the generation of functional tissue engineered constructs [57]. In contrast, our approach 
of whole organ perfusion decellularization reduces the diffusion distance required for 
decellularization agents to reach the cells and facilitates removal of the cellular material 
from the tissue by convective transport [53, 58, 59]. This technique allowed the efficient 
generation of acellular scaffold with preserved ECM, 3D architecture and perfusable 
network resembling a native organ (approximately 325 min as shown in our data Fig. 1D). 
The resulting decellularized pancreas met the stringent requirement to define a successful 
decellularization [48] - absence of nuclear material with DAPI and H&E staining, and 
retained only less than 50ng dsDNA per mg ECM dry weight as shown by quantitative DNA 
measurement (Fig. 1E–G). This requirement is crucial because residual DNA fragments in 
decellularized ECM have shown to lead to cytocompatibility issues in vitro and adverse 
immunological response upon implantation [49, 60, 61]. We and other groups have tried 
decellularization using similar strategies on other circulatory networks to reduce diffusion 
distance (e.g., bile duct in liver, pancreatic duct in pancreas) but it was much less effective 
likely due to incomplete distribution of a conduit network to reach all the cells throughout 
the target organ.
Another important consideration for organ decellularization is minimizing the undesirable 
alteration and loss of biologically active ECM components. Decellularized pancreas 
scaffolds demonstrated maintenance of key ECM proteins in adult pancreas [46, 47], 
including collagen I, collagen IV, laminin, and fibronectin, as well as sulfated GAG. Most of 
the ECM proteins retained their physiological organization after decellularization as noted 
by IHC (Fig. 2A). This finding was further substantiated by mass spectrometry analysis to 
comprehensively characterize the proteome of the decellularized pancreatic ECM. Retention 
of ECM protein/glycan compositions is typically characterized by IHC; this approach is 
however limited by its robustness and only confined to a small number of ECM candidates 
studied. Proteomic analysis by mass spectrometry is unbiased and does not require specific 
probes. Though our analysis was qualitative, notably all the top scoring proteins belonged to 
Goh et al. Page 13













the ECM family (supplemental table 1). These identifications have a high number of peptide 
spectral counts providing rough measures of protein abundance.
Biomechanical evaluation of engineered scaffolds and decellularized constructs is an 
important assessment for the rate of preservation of functional integrity. Numerous studies 
have shown that biomechanical properties change after decellularization of tissues [28, 62, 
63]. By using AFM, we measured the stiffness of the decellularized pancreas ECM. Our 
results demonstrated that Young’s modulus of decellularized pancreas is on average 3 times 
greater than the native pancreas (P<0.01, Fig. 4A, B). This is partially attributed to the loss 
of GAG content from the decellularization protocol (Fig. 2D). GAG proteins have a myriad 
of biological functions and some of them are associated with structural and biomechanical 
properties. GAGs possess a fixed negative charge that renders them hydrophilic and attracts 
water into the tissue causing an osmotic swelling, which in turn could contribute to tissue 
physical properties. Removal of GAG side chains by heparitinase/chondroitinase treatment 
has been shown to increase stiffness of basement membrane of tissue [11]. Although our 
result showed a higher Young’s modulus in decellularized pancreas than native pancreas, it 
is still well within the mechanical property range of “soft tissue” [64, 65]. While the 
magnitude of increase depends on the specific organ under study, some studies have shown 
that a slight alteration of tissue biomechanical properties was not associated with any 
detrimental effect on cellular functionality. For instance, successful repopulation of a cardiac 
matrix was demonstrated despite a higher tangential modulus was detected within the 
decellularized heart when compared to native rat ventricles [16], which is consistent with 
our findings.
Recent studies have suggested that the ECM composition and expression pattern are specific 
to a given anatomical location to direct or support site-appropriate cell attachment and 
function [25, 66]. In the native pancreas, the primary functional units of the pancreas divide 
easily into endocrine cells and exocrine cells. The endocrine cells are arranged mainly in 
groups as islets of Langerhans and secrete different polypeptides delivered to other parts of 
the body via the vasculature. In contrast, the secretions of acinar exocrine cells are carried 
away through the ductal system. To reconstitute the major functional processes in pancreas, 
we utilized these unique differential secretory channels to deliver two major pancreatic cell 
types–endocrine (β-cells) and exocrine (acinar cells)–in close proximity to their respective 
native niches. Our result showed that both cells types retained their functionality and distinct 
location upon recellularization (Fig. 8B, C).
Reestablishment of a critical ECM-β-cells interaction has been shown to improve β-cells 
survival and functions [15, 38, 40, 50–52]. In this study, we evaluated the effect of substrate 
on β-cell function. Insulin gene expression of MIN-6 cultured on Matrigel was found to be 
significantly higher than coated single purified proteins. This finding indicates that β-cells 
are responsive to ECM substrate differences. Hence it was expected that native pancreatic 
ECM scaffold with preserved native ECM milieu will also likely enhance insulin gene 
expression. Consistent to our hypothesis, ins1 and ins2 expression of MIN-6 cultured on 
decellularized pancreas 3D scaffold was higher than single purified molecules (P<0.05, Fig. 
9) and comparable to Matrigel (no statistical difference). However, 2D substrates of 
pancreatic ECM only showed similar level of insulin gene expression with single purified 
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molecules. This is likely due to the reason that pancreatic cell niche in vivo is a 3D 
environment and previous studies have shown that cell-matrix interaction in 3D matrices are 
more favorable from those on 2D substrates [67, 68]. Our result was supportive of this 
previous finding with the 3D pancreatic scaffold demonstrating better support of β-cell 
function. The high insulin gene expression observed when β-cells are cultured on Matrigel 
suggests the benefits of synergistic effects from multi-faceted ECM proteins. Similarly, 
decellularized pancreas scaffold also possesses multiplex ECM composition and the effects 
are proving to be similar when compared to Matrigel. Even though Matrigel is widely used 
in various tissue engineering studies, it is limited in its translational potential due to its 
tumor cell origin. In contrast, decellularized xenogenic sources of ECM scaffolds are 
typically regulated by the FDA as medical device and currently in wide clinical use [69]. 
Hence, the development of a bioscaffold using decellularized pancreatic ECM will provide a 
better clinical translation opportunity for pancreatic tissue engineering and regenerative 
medicine applications.
5. CONCLUSIONS
This report presents the first step toward successful decellularization and 3D reconstruction 
of whole pancreas. Thorough characterization revealed that the decellularized pancreas 
retained its native 3D architecture, vasculature and ductal channels along with important 
ECM compositions. The preserved pancreatic ECM scaffold was cytocompatible, supportive 
of representative pancreatic cell types, and enhanced insulin function when seeded with β-
cells. Such native organ derived scaffold is likely to have a great impact in pancreatic tissue 
engineering, by providing a niche microenvironment for pancreatic cell types and even stem/
progenitor cells.
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Figure 1. Perfusion-decellularization of murine pancreas
(A–D) Panel images depict gradual change of color from perfusion-decellularization of 
mouse pancreas with 0.5% SDS. Resulting decellularized pancreas after 325 min (D) 
appeared translucent. (E) Histological comparison of native and decellularized pancreas by 
H&E staining showed removal of cells. (F) IHC evaluation of native and decellularized 
pancreas depict presence of major pancreatic constituents (C-peptide–red, and Amylase–
green) in native pancreas (left) but absence in decellularized pancreas (right). (G) DNA 
quantification via picogreen analysis demonstrated less than 50ng/mg dry weight of DNA 
material present in the decellularized pancreas.
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Figure 2. ECM characterization of decellularized pancreas
(A) IHC staining showed the presence of major ECM composition–Col I, Col IV, 
Fibronectin, laminin and phalloidin actin staining (green) in native pancreas. (B) 
Comparison with decellularized pancreas, IHC staining demonstrated the corresponding 
ECM markers found in native pancreas also preserved in decellularized markers but DAPI 
and actin cytoskeletal element were absent. This indicates complete removal of cellular 
materials but preservation of important ECM proteins. (C) Alcian blue staining qualitatively 
determined the retention of sGAG protein after decellularization. (D) Blyscan assays 
quantitatively determined the sGAG retention in decellularized pancreas was on average 
52% of that in native pancreas (P<0.05).
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Figure 3. Ultrastructural characterization of decellularized pancreas
(A) Trypan blue dye infusion visualized the progressive flow from large vessels to the fine 
blood vessel branches along the channels without leakage. Inset shows light microscopy 
image of vasculature branches remained intact after decellularization. (B) TEM of 
decellularized pancreas depicted the intact basement membrane (arrowhead points to the 
underlying basement membrane). (C) TEM image of decellularized pancreas showed the 
interstitial space with organized fibers of collagen (arrowhead). (D–E) SEM comparison of 
native and decellularized pancreas demonstrated preservation of 3D microstructure of 
pancreatic duct after decellularization. Inset shows the absence of lining ciliated microvilli 
cells from the luminal surface of the duct after decellularization process. (F) SEM image of 
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decellularized pancreas showed ECM fibers within the parenchymal space. (G) Higher 
magnification of 3D meshwork showed a variety of fibers - large bundle of Type I collagen 
(black arrowhead) associated with a variety of smaller fibers (white arrowhead). (H) SEM 
image of decellularized pancreas demonstrated large/small fibers interlinked in a plane that 
forms a boundary such as to previously occupied pancreatic parenchymal cells. (I) SEM 
image of decellularized pancreas demonstrated scalloping appearance of the internal elastic 
lamina of an artery, indicating intact blood vessel (BV).
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Figure 4. Biomechanical properties of decellularization pancreas
(A) Representative deflection plot from AFM evaluation of native and decellularized 
pancreas shows a steeper slope than force curve of decellularized pancreas from native 
pancreas, indicating higher Young’s modulus. (B) Bar graph representatives of AFM force 
curve shows on average 3 times higher stiffness in the decellularized pancreas than native 
pancreas.
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Figure 5. Biocompatibility of perfusion-decellularized pancreas ECM
A perfusion-decellularized pancreas ECM construct was surgically implanted within a 
subcutaneous pocket in a C57Bl/6 mouse model. After 14 days Mason’s trichrome staining 
of the implant site (A) showed the ECM scaffold (#) infiltrated with host mononuclear cells. 
H&E staining (B) showed no signs of multinucleate giant cells and the presence of blood 
vessel (arrows). (Scale bars = 50μm, inset = low power magnification, inset scale bar = 
200μm)
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Figure 6. MIN-6 culture on 2D slice pancreatic matrix
(A) Diagram illustrates the generation of 2D pancreatic slice. White dashed circle depict the 
cloning cylinder applied to pancreatic slice to consolidate seeded cells to pancreatic 
substrate. (B) Multi-photon imaging on second harmonic generation (SHG) signal to 
visualize the collagen fibers demonstrated that thickness of the 2D slice pancreatic matrix is 
about 10–20 μm. (C) H&E staining demonstrated the attachment of MIN-6 cells on 2D 
pancreatic slice after 5 days of culture, and insulin expression (C-peptide: green) was 
maintained.
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Figure 7. Recellularization of decellularized pancreas
(A) Decellularized whole pancreas before cell seeding. (B) Recellularization of the same 
pancreas via multi-step infusion of about 30 million cells via portal vein infusion. (C) H&E 
staining of the recellularized pancreas after 5 days showed the engraftment of the seeded 
cells at surrounding parenchymal region. (D) TUNEL staining of the recellularized construct 
showed less than 18% of apoptotic cells (arrowhead), demonstrating the cytocompatibility 
of the scaffold. (E) Positive control of TUNEL staining by adding DNAse to the consecutive 
sections of recellularized pancreas’s histological slide. (F) IHC of recellularized pancreas 
with MIN-6 only showed C-peptide+ cells engraftment around the larger vessel 
(arrowhead).
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Figure 8. Dual recellularization strategy with ƒÀ- and acinar cell types
(A) Two different cell types (MIN-6 and AR42J) were inoculated into the decellularized 
pancreas 3D scaffold utilizing two different seeding routes. (B) IHC of recellularization with 
both MIN-6 and AR42J cell lines showed engraftment of both cell types. Both cell types 
maintained their respective functional markers–MIN-6 (Cpeptide–green) and AR42J 
(Amylase–red). (C) Vasculature and pancreatic duct situated next to each other with their 
respective seeded different population of cells (vasculature-MIN6 and duct-AR42J). Inset 
shows single channel images. This indicates that preservation of architecture of vasculature 
and ductal structure, hence different cell population were not inter-dispersed after seeding.
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Figure 9. Comparison of ECM mediated insulin gene expression of MIN-6 cells
qPCR data demonstrated modulation of MIN-6 cell insulin gene expression by different 
types of ECM protein. 3D Pancreatic ECM demonstrated higher ins1 and ins2 genes 
expression than Collagen I, Collagen IV, Fibronectin and 2D pancreatic slice ECM but only 
comparable to Matrigel. Normalization was performed to MIN-6 cells seeded on control 
non-tissue culture treated plastic. * indicates P<0.05
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Table 1
Mass Spectrometry Composition Analysis
Protein Family Gene Description
Collagens Col6a3 Collagen alpha-3(VI) chain
Col1a2 Collagen alpha-2(I) chain
Col4a2 Collagen alpha-2(IV) chain
Col4a1 Collagen alpha-1(IV) chain




Col5a1 Collagen alpha-1(V) chain
Col3a1 Collagen alpha-1(III)
Col14a1 Collagen alpha-1(XIV) chain
Col6a6 Collagen alpha-6(VI) chain
Col5a3 Procollagen, type V, alpha 3
Col7a1 Col7a1 Collagen alpha-1(VII) chain
Gm7455 Collagen alpha-5(VI) chain
Col4a3 Collagen alpha-3(IV) chain
Col18a1 Collagen alpha-1(XVIII) chain
Laminin Lamb2 Laminin subunit beta-2
Lamc1 Laminin subunit gamma-1
Lama2 Laminin subunit alpha-2
Lama5 Laminin subunit alpha-5
Lamb1 Laminin subunit beta-1
Lama1 Laminin subunit alpha-1
Lama4 Laminin subunit alpha-4




Elastin associated Fbn1 Fibrillin-1
Matricellular Tnxb Tenascin-X
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